Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Programmed Death ◽

Epidermal Growth ◽

Receptor Mutant

Programmed death ligand 1 protein expression is positively correlated with the solid predominant subtype, high MIB-1 labeling index, and p53 expression and negatively correlated with epidermal growth factor receptor mutations in lung adenocarcinoma

Human Pathology ◽

10.1016/j.humpath.2020.10.014 ◽

2021 ◽

Vol 108 ◽

pp. 12-21

Author(s):

Naoki Yanagawa ◽

Satoshi Shiono ◽

Makoto Endo ◽

Shin-ya Ogata ◽

Noriyuki Yamada ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Growth Factor Receptor ◽

P53 Expression ◽

Programmed Death ◽

Epidermal Growth ◽

Mib 1

Programmed Death-Ligand 1 Expression Predicts Tyrosine Kinase Inhibitor Response and Better Prognosis in a Cohort of Patients With Epidermal Growth Factor Receptor Mutation-Positive Lung Adenocarcinoma

Clinical Lung Cancer ◽

10.1016/j.cllc.2015.02.002 ◽

2015 ◽

Vol 16 (5) ◽

pp. e25-e35 ◽

Cited By ~ 56

Author(s):

Cheng Lin ◽

Xiong Chen ◽

Meifang Li ◽

Jingnan Liu ◽

Xingfeng Qi ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Programmed Death ◽

Two cases of response to pembrolizumab in epidermal growth factor receptor mutated lung adenocarcinoma patients with programmed death-ligand 1 overexpression

Annals of Translational Medicine ◽

10.21037/atm.2018.10.24 ◽

2018 ◽

Vol 6 (22) ◽

pp. 444-444 ◽

Cited By ~ 1

Author(s):

Takeshi Uenami ◽

Mikako Ishijima ◽

Masaki Kanazu ◽

Hiroyuki Kurebe ◽

Ryuya Edahiro ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Growth Factor Receptor ◽

Programmed Death ◽

TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinib

Translational Oncology ◽

10.1016/j.tranon.2021.101163 ◽

2021 ◽

Vol 14 (9) ◽

pp. 101163

Author(s):

Ruofei Yu ◽

Hua Bai ◽

Tangai Li ◽

Bingyu Gao ◽

Jiefei Han ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Growth Factor Receptor ◽

Circulating Tumor Dna ◽

Tp53 Mutations ◽

Epidermal Growth ◽

Receptor Mutant ◽

Tumor Dna

Association of BMI With Benefit of Metformin Plus Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors in Patients With Advanced Lung Adenocarcinoma

JAMA Oncology ◽

10.1001/jamaoncol.2021.7015 ◽

2022 ◽

Author(s):

Oscar Arrieta ◽

Zyanya Lucia Zatarain-Barrón ◽

Jenny G. Turcott ◽

Feliciano Barrón ◽

Sai Yendamuri ◽

...

Keyword(s):

Receptor Tyrosine Kinase Inhibitors

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Potential Resistance Mechanisms Revealed by Targeted Sequencing from Lung Adenocarcinoma Patients with Primary Resistance to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs)

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2017.07.032 ◽

2017 ◽

Vol 12 (12) ◽

pp. 1766-1778 ◽

Cited By ~ 15

Author(s):

Jia Zhong ◽

Lei Li ◽

Zhijie Wang ◽

Hua Bai ◽

Fei Gai ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Resistance Mechanisms ◽

Primary Resistance ◽

Egfr Tyrosine Kinase Inhibitors ◽

Epidermal Growth Factor Receptor Mutations as a Prognostic Factor in Korean Patients with Advanced Lung Adenocarcinoma Who Had Not Been Treated with Received Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Chemotherapy ◽

10.1159/000321490 ◽

2011 ◽

Vol 57 (2) ◽

pp. 108-114 ◽

Cited By ~ 1

Author(s):

Seung Tae Kim ◽

Yoon Ji Choi ◽

Kyong Hwa Park ◽

Sang Cheul Oh ◽

Jae Hong Seo ◽

...

Keyword(s):

Receptor Tyrosine Kinase Inhibitors

Growth Factor ◽

Prognostic Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Radiotherapy Upregulates Programmed Death Ligand-1 through the Pathways Downstream of Epidermal Growth Factor Receptor in Glioma

EBioMedicine ◽

10.1016/j.ebiom.2018.01.027 ◽

2018 ◽

Vol 28 ◽

pp. 105-113 ◽

Cited By ~ 14

Author(s):

Xing Song ◽

Yingjie Shao ◽

Tianwei Jiang ◽

Yun Ding ◽

Bin Xu ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Programmed Death ◽

Epidermal Growth Factor Receptor (EGFR)–Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR-Mutant Lung Adenocarcinoma

Targeted Oncology ◽

10.1007/s11523-019-00649-1 ◽

2019 ◽

Vol 14 (4) ◽

pp. 423-431

Author(s):

Changhui Li ◽

Bo Zhang ◽

Jindong Guo ◽

Fang Hu ◽

Wei Nie ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Brain Metastasis ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Egfr Tyrosine Kinase Inhibitors ◽

Epidermal Growth ◽

Egfr Mutant

Programmed death-ligand 1 is prognostic factor in esophageal squamous cell carcinoma and is associated with epidermal growth factor receptor

Cancer Science ◽

10.1111/cas.13197 ◽

2017 ◽

Vol 108 (4) ◽

pp. 590-597 ◽

Cited By ~ 15

Author(s):

Wencheng Zhang ◽

Qingsong Pang ◽

Xiaodong Zhang ◽

Cihui Yan ◽

Qifeng Wang ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Growth Factor ◽

Prognostic Factor ◽

Epidermal Growth Factor ◽

Esophageal Squamous Cell Carcinoma ◽

Growth Factor Receptor ◽

Programmed Death ◽